IWQOL-Lite-Clinical Trials

IWQOL-Lite Clinical Trials

To meet the developmental rigor required by the Food and Drug Administration (FDA) to support product labeling, an alternative version of the IWQOL-Lite questionnaire - IWQOL-Lite-Clinical Trials© (IWQOL-Lite-CT) - has been developed and refined through two qualitative studies.
The IWQOL-Lite-CT consists of 20 items optimized for use in the adult patient population typically targeted for obesity clinical trials, both with and without type 2 diabetes.
Once quantitative data become available, tests of reliability, validity and responsiveness will be conducted and a scoring algorithm will be developed for the IWQOL-Lite-CT.
It is anticipated that the final measure will be qualified by the FDA for use in clinical trials of new weight-loss medications to support product labeling claims.

Licensing IWQOL-Lite CT

Licensing for IWQOL-Lite-CT is managed solely through Pattern Health, a passionate team of technologists, clinicians and behavioral researchers whose vision is to make healthcare more efficient and effective by creating products that empower patient self-care and research.

The new digital versions, which can be used standalone or integrated into digital care plans and clinical trials, will be more accessible and engaging for patients while improving the accuracy and reliability of the collected data.

Click the button below to engage Pattern Health with questions or licensing information.

Click for Information and Licensing

Download the Poster Presented at Obesity Week 2018

“Validation of a New Measure of Quality of Life in Obesity Trials: IWQOL-Lite Clinical Trials Version” is a poster presented at Obesity Week, November 11-15, 2018, Nashville, TN, United States. Click here to download the PDF.